Abstract. The current study reports the case of a 15-year-old male who presented with hearing loss due to a small left-sided vestibular schwannoma (VS) not associated with neurofibromatosis type 2 (NF2), which had been apparent for six months. Magnetic resonance imaging with gadolinium diethylenetriamine penta-acetic acid revealed a mass, 10 mm in diameter, located in the left inner auditory canal. The patient had no family history of NF2 and gene mutation analysis showed no signs of the condition. Small sporadic or non-NF2 VS is extremely rare and the treatment decision-making process is complicated in children when considering the implications for the impairment of childhood development and lifelong disability. Following careful consideration, the patient in the present study underwent treatment with stereotactic radiosurgery. The five-year post-operative follow-up examination showed tumor stability without additional neurological deficits and at the time of writing the patient was alive and well.
Introduction
Vestibular schwannomas (VSs) are histologically benign tumors that originate from the vestibular division of the eighth cranial nerve. The tumors may occur sporadically, most commonly in the fifth decade of life and later, or as part of the clinical complex in neurofibromatosis type 2 (NF2), which occurs bilaterally and in young individuals. Sporadic or non-NF2 VSs are extremely rare in pediatric patients (1) .
Currently, there are a variety of treatment options for the management of VSs, including observation with serial imaging, radiosurgery and microsurgery (2) . The range of tumor volumes and growth patterns make the management of these lesions an issue that is much debated. Due to the clinical heterogeneity among patients with VSs, no standard patient management has been reported (3). Pediatric patients with small VSs can be challenging to neurosurgeons.
In the present study we discuss the presentation, treatment course and follow-up outcome for a pediatric patient with sporadic unilateral VSs and reviewed other related literature. This study aims to explore the current treatment paradigm for sporadic Vss in the pediatric population. Written informed consent was obtained from the patient's family for publication of this case study and the accompanying images.
Case report
In March 2009, a 15-year-old male, previously in good health, presented to Tongji Hospital, Huazhong University of Science and Technology (Wuhan, China) with complaints of left-sided progressive hearing loss that had been apparent for six months. Upon examination, left-sided sensorineural hearing loss of 60 dB was found, with no other neurological impairments. Cerebral computed tomography revealed an enlarged inner auditory canal on the left side (Fig. 1A) . Magnetic resonance imaging (MRI) with gadolinium diethylenetriamine penta-acetic acid demonstrated a mass that was entirely located in the inner auditory canal, measuring 10 mm at its largest diameter (Fig. 1B) . Homogeneous enhancement was documented on contrast MRI. The patient had no family history of NF2 and gene mutation analysis showed no signs of the condition. Following a discussion on the risks and benefits of microsurgery versus γ-knife surgery, and subsequent to conservative observation with a series of images, the patient chose radiosurgery treatment, which was administered once at a dose of 11.7 Gy. Following radiosurgery, the patient was discharged with left-sided hearing loss. No other neurological complaints or findings were observable on a physical examination. At 36 months post-treatment, the patient exhibited no identifiable tumor enlargement. Within the literature, the treatment strategies for small VSs are varied, making it difficult for a neurosurgeon to decide the best course of action (4, 7, 8) . In a study from the US, the strongest predictors of treatment modality were patient age and tumor size (3). The treatment decision rests on the availability of information with regard to the characteristics of the patient and the tumor. The decision is often hard due to inconsistencies in the data on the natural history of VS, the mechanism of hearing loss, and the hearing and facial function preservation rates associated with treatment (9) . This variability is a major obstacle to practicing evidence-based medicine. The dilemma in treatment decision-making is complicated in children due to implications for the impairment of childhood development and lifelong disability. The first concern is preservation of facial nerve function, which is paramount, particularly in children, as it is often regarded as the most important index for quality of life post-operatively (5).
It has been suggested that certain factors, including the preference of the patient toward risk-aversion, the relative weight of discomfort at the present time versus the possible loss of function in the future, and the degree of comfort with regard to an uncertain long-term prognosis following radiation or during observation, will heavily effect the treatment decision (10) . For the present patient, a summary of information on all three management options was provided. While radiosurgery was recommended to this pediatric patient with a small tumor, observation and surgery were also discussed, and the pros and cons of these treatment options were conveyed. This dialogue can avoid later dispute concerning the treatment of other individuals using means that the patient had not been told about, which can easily lead to distrust and even discrepancy.
All three treatment options may have been of optimal use for this case in the present medical environment. More objective data on treatment comparisons in VS management in the future will provide further evidence to aid patients and neurosurgeon in the decision-making process with a rational basis. Outcome measures should include quality of life, using a scaling system specifically designed for this entity. The treatment strategies for small VSs in pediatric patients should be tailored to the clinical, personal and social requirements of the patient. However, a rigid treatment protocol is not practical at present, and the treatment decision-making for this type of lesion is always an art form in itself.
To conclude, in the present case the treatment method without randomized controlled trial evidence was chosen on an individual basis, taking into consideration the patient's preferences, clinician experience and the availability of radiosurgical equipment. γ-knife radiosurgery was confirmed to provide long-term tumor control for sporadic small sized vestibular schwannoma in pediatric patients. The risk for loss of hearing is high, whereas the risk for other cranial nerve complications is low. Therefore, radiosurgical treatment should be considered for the management of sporadic small VS in pediatric patients if imaging indicates a small tumor size. Future studies using large patient cohorts are required to establish a standard treatment procedure for this condition. A B
